NCT06403436 2026-04-13
TT-CSP-001
TOLREMO therapeutics AG
Phase 1 Active not recruiting
TOLREMO therapeutics AG
Peter MacCallum Cancer Centre, Australia
National Institutes of Health Clinical Center (CC)
Brigham and Women's Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)